A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.

Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F, Emtricitabine FTCB-301 Study Group
Arch Intern Med. 2006 166 (1): 49-56

PMID: 16401810 · DOI:10.1001/archinte.166.1.49

MeSH Terms (21)

Adult Aged Alanine Transaminase Antiviral Agents Biopsy, Needle Deoxycytidine DNA, Viral Double-Blind Method Emtricitabine Female Genotype Hepatitis B, Chronic Hepatitis B Antibodies Hepatitis B virus Humans Liver Male Middle Aged Placebo Effect Treatment Outcome Viral Load

Connections (1)

This publication is referenced by other Labnodes entities:

Links